Related by context. Frequent words. (Click for all words.) 69 CORT # 67 DNA RNA Medicines 67 Panzem R 66 CCX# 66 Harbor BioSciences 66 novel orally administered 66 sodium Injection 65 Copegus R 65 Onalta 65 liposomal formulation 64 Aganocide compounds 64 MEK inhibitor 64 RGB # 64 Azedra 64 HCV protease inhibitor 64 polymerase inhibitors 64 ALN TTR# 63 Guanilib 63 Kuvan R 63 www.polymedix.com 63 multi kinase inhibitor 63 Advancing Drugs 63 HCV protease 63 Medarex logo 63 Recombinant Human 63 NovaBay 63 PEG SN# 62 therapeutic monoclonal antibodies 62 BioWa 62 Hybridon 62 anticancer compound 62 CK # novel 62 Chrysalin 62 FermaVir 62 proteasome inhibitor 62 VIA Pharmaceuticals 61 ATL# [001] 61 Inc Therapeutic Competitors 61 DAVANAT 61 Tesetaxel 61 Cetrorelix 61 nitric oxide donating 61 Factor VIIa 61 R sorafenib tablets 61 www.syntapharma.com 61 Genasense R oblimersen 61 novel antibody therapeutics 61 targeting CD# 61 ganetespib 61 Captisol 61 Proxinium TM 61 Pivotal Phase III 61 BiTE antibody 61 nicotinic alpha 7 60 Shigamabs ® 60 Icatibant 60 #ME# 60 immunomodulating 60 Belimumab 60 neuroprotective properties 60 AZX# 60 nanoviricides 60 antifungal agent 60 novel anticancer 60 MGCD# [001] 60 Sym# 60 Phase 2a trial 60 ASONEP 60 generation antisense 60 Gemzar ® 60 AeroLEF R 60 refractory chronic lymphocytic 60 ImmuneRegen BioSciences Inc. 60 Linaclotide 60 talactoferrin 60 Inc. Nasdaq IMGN 60 thymalfasin 60 Transcept Pharmaceuticals 60 Phenoptin 60 Traficet EN 59 www.combinatorx.com 59 Phase III Clinical Trial 59 tezampanel 59 GAP #B# 59 Idera Pharmaceuticals 59 immunomodulatory 59 BEMA TM Fentanyl 59 KNS # 59 Protexia R 59 Presents Positive 59 Veronate 59 Elesclomol 59 IND submission 59 SAR# [004] 59 PCK# 59 Barrier Therapeutics Inc. 59 ALN VSP 59 EZN 59 DDP# 59 Promedior 59 CD# expressing